Mice lacking CCL2 are protected from bleomycin-induced dermal fibrosis [48], while mice lacking the CCL2 receptor CCR2 are protected from bleomycin-induced lung fibrosis [49,50]. The gene discussed is CCR2; the disease is pulmonary fibrosis.